Your browser is no longer supported. Please, upgrade your browser.
Settings
TEVA Teva Pharmaceutical Industries Limited daily Stock Chart
TEVA [NYSE]
Teva Pharmaceutical Industries Limited
Index- P/E213.10 EPS (ttm)0.16 Insider Own2.70% Shs Outstand1.02B Perf Week-1.67%
Market Cap33.76B Forward P/E6.91 EPS next Y4.78 Insider Trans0.00% Shs Float913.43M Perf Month-5.75%
Income68.00M PEG86.45 EPS next Q1.07 Inst Own63.20% Short Float2.39% Perf Quarter-9.65%
Sales21.90B P/S1.54 EPS this Y-96.10% Inst Trans10.40% Short Ratio2.07 Perf Half Y-34.62%
Book/sh29.28 P/B1.13 EPS next Y0.15% ROA0.10% Target Price40.13 Perf Year-36.70%
Cash/sh0.98 P/C33.83 EPS next 5Y2.47% ROE0.20% 52W Range31.60 - 56.35 Perf YTD-8.01%
Dividend1.36 P/FCF11.18 EPS past 5Y-53.00% ROI1.10% 52W High-41.38% Beta0.64
Dividend %4.12% Quick Ratio0.60 Sales past 5Y3.60% Gross Margin54.10% 52W Low4.54% ATR0.80
Employees56960 Current Ratio0.90 Sales Q/Q33.00% Oper. Margin9.80% RSI (14)44.51 Volatility2.41% 2.04%
OptionableYes Debt/Eq1.20 EPS Q/Q-284.70% Profit Margin0.30% Rel Volume0.54 Prev Close32.76
ShortableYes LT Debt/Eq1.09 EarningsFeb 13 BMO Payout835.30% Avg Volume10.56M Price33.03
Recom2.40 SMA20-1.95% SMA50-2.23% SMA200-22.15% Volume5,676,473 Change0.82%
Feb-28-17Downgrade Argus Buy → Hold
Feb-13-17Reiterated Maxim Group Hold $41 → $40
Feb-10-17Downgrade Mizuho Buy → Neutral $40 → $27
Jan-31-17Upgrade BofA/Merrill Neutral → Buy
Jan-31-17Reiterated Barclays Equal Weight $46 → $38
Jan-20-17Downgrade JP Morgan Overweight → Neutral
Jan-09-17Downgrade Wells Fargo Outperform → Market Perform
Jan-06-17Downgrade Maxim Group Buy → Hold $49 → $41
Jan-03-17Reiterated Maxim Group Buy $52 → $49
Dec-07-16Resumed Oppenheimer Outperform
Nov-16-16Reiterated RBC Capital Mkts Outperform $58 → $51
Nov-16-16Reiterated Mizuho Neutral $45 → $40
Nov-16-16Reiterated Maxim Group Buy $72 → $52
Nov-16-16Reiterated Deutsche Bank Buy $68 → $54
Nov-16-16Downgrade Morgan Stanley Overweight → Equal-Weight
Nov-16-16Downgrade Jefferies Buy → Hold $69 → $40
Nov-14-16Resumed Barclays Equal Weight $46
Nov-14-16Reiterated RBC Capital Mkts Outperform $71 → $58
Nov-07-16Downgrade BofA/Merrill Buy → Neutral
Nov-04-16Downgrade HSBC Securities Buy → Hold
Mar-27-17 07:00PM  Risk-Reward With Teva Pharmaceutical
08:35AM  Major Pharma Short Sellers Couldnt Make Up Their Minds Before Failed Trump Health Care Vote
Mar-24-17 10:54AM  Teva Pharma Denies Rumors of Global Workforce Reduction
Mar-23-17 10:16AM  Mylan Stock Dips On Recall Of 81,000 EpiPens Outside U.S.
09:06AM  Teva Denies Reports About 11% Global Workforce Reduction (TEVA) at Investopedia
06:52AM  Teva Pharm says media reports of up to 6,000 layoffs incorrect
04:30AM  Teva Pharm may fire 6,000 workers: Israeli media report
04:19AM  Teva Pharm may fire 6,000 workers -Israeli media report
03:33AM  Teva to Cut Undisclosed Number of Jobs as It Seeks to Pare Costs
03:33AM  Teva to Cut as Many as 6,000 Jobs, Calcalist Newspaper Reports
Mar-21-17 10:53AM  Nektar's Pain Drug Positive in Phase III Study; Shares Gain
Mar-20-17 08:10PM  Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Launches Minastrin Generic In The United States at Insider Monkey
10:32AM  AstraZeneca (AZN) Gets Another CRL for ZS-9; Inks COPD Deal
Mar-17-17 09:58AM  Teva Launches Authorized Generic of Allergan's Minastrin
Mar-16-17 01:58PM  Teva Announces Launch of Authorized Generic of Minastrin® 24 Fe (norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets) in the United States Business Wire
Mar-14-17 07:02AM  3 High-Yield Investments in Healthcare at Motley Fool
Mar-13-17 11:18AM  Billionaire David Tepper Makes Huge Investments In These 4 Drug Stocks at Insider Monkey
11:00AM  Teva to Present at the Barclays Global Annual Healthcare Conference Business Wire
Mar-09-17 12:00PM  Why Battered Biotech Teva Is a Smart Contrarian Buy Right Now
Mar-08-17 01:52PM  The Tepper blitz on The Halftime Report
07:50AM  David Tepper's big bet in pharma
Mar-07-17 04:25PM  These Pharma Stocks Are Big Losers From Trump's Drug-Pricing Tweet
Mar-06-17 12:49PM  TD Ameritrade's Investor Movement Index (IMX) For February 2017
10:56AM  Teva to Present at the Cowen & Company 37th Annual Healthcare Conference Business Wire
Mar-05-17 11:41AM  3 Tempting Stocks to Avoid at Motley Fool
Mar-03-17 10:25AM  Perrigo Joins Firms With Generic Drugs Under U.S. Glare
06:00AM  Mylan's Governance May Be the Root of Its Problems
Mar-02-17 01:15PM  Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Mylan N.V. (MYL) Accused Of Price Fixing By 20 More States at Insider Monkey
Mar-01-17 04:53PM  Twenty More States Accuse Mylan, Teva and Others of Price Collusion
10:56AM  Teva Announces Launch of Generic Pristiq® in the United States Business Wire
10:10AM  Priority Review Granted To Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Tardive Dyskinesia Drug at Insider Monkey
Feb-28-17 04:33PM  Teva Downgraded On Lost MS Drug Patents, DOJ Probe
08:55AM  Why Short Sellers Are Making a Massive Bet in Major Pharma
08:35AM  FDA to expedite review of Teva drug for movement disorder Reuters
08:00AM  Teva Announces Priority Review Granted by FDA for SD-809 for Treatment of Tardive Dyskinesia Business Wire
07:58AM  Teva Pharma downgraded by Argus
Feb-27-17 08:55AM  3 Surprising Big-Brand Stocks Billionaires Sold Heavily Last Quarter at Motley Fool
07:57AM  These 3 Big Pharma Stocks Are Ridiculously Cheap at Motley Fool
07:36AM  Eli Lilly & Co.s Neuroscience Franchise
Feb-24-17 12:57PM  3 Cheap Healthcare Stocks You Can Buy Right Now at Motley Fool
Feb-23-17 09:23PM  3 Stocks the Market Is Wrong About at Motley Fool
05:06PM  Teva Is Expected to See a Fall in Its Profit Margins in 2017
03:36PM  Teva Is Expected to Witness a Modest Revenue Rise in 2017
01:50PM  What Analysts Recommend for Teva Pharmaceutical in 2017
12:03PM  Billionaire Andreas Halvorsens Viking Global Cuts Losses and Dumps Southwestern Energy and Teva Pharmaceutical, Still Bullish on Bank of America at Insider Monkey
Feb-22-17 02:02PM  Manufacturing Delay Of Generic Drug From Pfizer Inc. (PFE) A Relief For Teva Pharmaceutical Industries Ltd (ADR) (TEVA) at Insider Monkey
01:04PM  TEVA PHARMACEUTICAL INDUSTRIES LTD Financials
08:29AM  Drug Stocks Q4 Earnings Slated for Feb 23: BMRN, ICPT & More
Feb-21-17 12:37PM  Momenta, Pfizer Give Teva Pharma Breathing Room On Generic MS Drug
12:26PM  Why Momenta Pharmaceuticals, Inc. Shares Got Crushed Today at Motley Fool
09:36AM  Teva Shares Get a Boost in Early Trading at Investopedia
Feb-20-17 04:40PM  Billionaire Value Investor Michael Price Adds Specialty Retailer and a REIT to Its 13F Portfolio at Insider Monkey
08:24AM  3 Top Drug Stocks That Can Be Purchased on the Cheap This Winter at Motley Fool
07:37AM  This Keeps Driving Sanofis Growth
06:52AM  Drug Stocks Q4 Earnings Lineup for Feb 21: IRWD, MNTA, EXAS
Feb-17-17 10:36AM  Amgen Is Managing the Life Cycle of Its Mature Nephrology Drugs in 2017
10:35AM  If You're in Your 30s, Consider Buying These Stocks at Motley Fool
09:07AM  Parsabiv Is Expected to Boost Amgens Revenues in 2017
Feb-16-17 06:55PM  Why This Billionaire Just Shelled Out $1.1 Billion on 4 Drug Stocks at Motley Fool
12:06PM  David Tepper Invests Heavily in Pharma in 4th Quarter
09:31AM  What's Driving Lilly's (LLY) Shares after 2016 Decline?
03:25AM  Multinationals learn the limits of being big at MarketWatch
Feb-15-17 06:10PM  Teva Files 2016 Annual Report on Form 20-F Business Wire +5.36%
04:45PM  Acorda Must Stave Off Mylan, Teva Generics To Protect Ampyra: RBC
12:35PM  Teva Pharmaceutical Industries Ltd. :TEVA-US: Earnings Analysis: 2016 By the Numbers : February 15, 2017
Feb-14-17 03:10PM  Some of biotech's biggest names have acquired this Md. company at bizjournals.com
10:10AM  Company News for February 14, 2017
09:45AM  Teva Pharmaceutical Industries Ltd. :TEVA-US: Earnings Analysis: Q4, 2016 By the Numbers : February 14, 2017
09:45AM  Today's Research Reports on Stocks to Watch: Teva Pharmaceutical Industries and Allergan Accesswire
08:55AM  Top Analyst Upgrades and Downgrades: Intuitive Surgical, Restaurant Brands, Scorpio Tankers, Teva, Under Armour, Zillow and Many More
08:20AM  Teva (TEVA) Tops on Q4 Earnings, Maintains 2017 Guidance
12:42AM  [$$] Teva Swings to Loss on Write-Down But Beats Expectations at The Wall Street Journal
Feb-13-17 10:40PM  Teva Pharmaceutical Industries Ltd. Reports Q4 Improvement Thanks to Actavis Deal at Motley Fool +5.62%
04:01PM  Teva Maintains 2017 Guidance Despite Copaxone Patent Losses; Q4 Tops
02:53PM  Troubling Trends Seen in Teva's FY16 Results at Investopedia
01:26PM  How to Trade Monday's Most Active Stocks: BofA, Vale, Zeltiq, Teva and More
01:02PM  3 Bargain-Bin High-Yield Dividend Stocks You've Overlooked This Winter at Motley Fool
12:37PM  Teva Tries Out 'Alternative Guidance' at Bloomberg
11:35AM  Teva Said to Weigh Options for Branded Generics to Reduce Debt
11:35AM  Teva Said to Consider Options for Branded Generics Unit at Bloomberg
11:11AM  Allergan Shares Rise on $2.5B Deal for Body-Sculptor Zeltiq
11:00AM  Teva Faces Uncertainty
10:31AM  Teva seeks CEO with pharma background to lead recovery efforts Reuters
10:27AM  Markets Climb Amid Solid Q4 Earnings
10:07AM  Teva Climbs On Upbeat Q4 Earnings, Reaffirmed Guidance at Barrons.com
10:02AM  Teva Claws Its Way Back With Earnings, Revenue Beat
09:39AM  Morning Movers: Verizon Falls, Teva Jumps, Hain Celestial Craters at Barrons.com
08:53AM  [$$] Teva Swings to Loss, But Beats Expectations at The Wall Street Journal
08:44AM  Teva Gets Actavis Boost, Q4 Results Top Estimates
08:34AM  Teva (TEVA) Tops Q4 Earnings & Sales Estimates; Shares Up
07:55AM  How Rosy Is the Outlook for Teva Pharmaceutical?
07:17AM  Market Recon: The Foundation Is Laid to Support This Rally
07:02AM  Teva Pharm Q4 profit, revenue beat expectations Reuters
06:42AM  Teva Reports Full Year and Fourth Quarter 2016 Financial Results Business Wire
05:45AM  U.S. stocks on pace to continue their run of records at MarketWatch
Feb-11-17 08:24AM  Earnings Preview: What To Expect From Teva Pharmaceutical On Monday at Forbes
Feb-10-17 06:52PM  Cramers game plan: Spotting the perfect combination for ...
06:42PM  [video]Game Plan for the Week Ahead: Cramer's 'Mad Money' Recap (Friday 2/10/17)
12:00PM  Is More Downside Ahead For Teva Pharmaceutical? at Barrons.com
08:35AM  Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. It operates through two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. This segment also develops, manufactures, and sells active pharmaceutical ingredients. The Specialty Medicines segment provides branded specialty medicines for use in central nervous system and respiratory indications, as well as the women's health, oncology, and other specialty businesses. Its products in the central nervous system area comprise Copaxone for multiple sclerosis; Azilect for the treatment of Parkinson's disease; and Nuvigil for the treatment of excessive sleepiness associated with narcolepsy and certain other disorders. This segment's products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Qnasl, Braltus, Cinqair/Cinqaero, and Aerivio Spiromax for the treatment of asthma and chronic obstructive pulmonary disease, as well as Treanda/Bendeka, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. This segment also offers a portfolio of products in the women's health category, which includes ParaGard, Plan B One-Step, and OTC/Rx, as well as other products. The company has collaboration arrangements with Attenukine, Procter & Gamble Company, and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.